Download App

Log in to access Online Inquiry
Company Overview More
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; HTX-019, an investigational agent for the prevention of postoperative nausea and vomiting; and HTX-034 for postoperative pain management, as well as is in Phase Ib/II clinical study in patients undergoing bunionectomy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
CEO: Quart Pharm.D., Barry D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > HRTX Heron Therapeutics > Detailed Quotes

HRTX Heron Therapeutics

3.180+0.080+2.58%
Close 05/26 20:00 ET
High
3.270
Open
3.110
Turnover
10.47M
Low
3.050
Pre Close
3.100
Volume
3.33M
Market Cap
325.89M
P/E(TTM)
Loss
52wk High
16.630
Shares
102.48M
P/E(Static)
Loss
52wk Low
3.050
Float Cap
246.72M
Bid/Ask %
81.82%
Historical High
830.000
Shs Float
77.59M
Volume Ratio
1.66
Historical Low
2.002
Dividend TTM
--
Div Yield TTM
95
P/B
13.59
Dividend LFY
--
Div Yield LFY
2987.42%
Turnover Ratio
4.29%
Amplitude
7.10%
Avg Price
3.148
Lot Size
1
Float Cap
246.72M
Bid/Ask %
81.82%
Historical High
830.000
Shs Float
77.59M
Volume Ratio
1.66
Historical Low
2.002
Dividend TTM
--
P/B
13.59
Dividend LFY
--
Turnover Ratio
4.29%
Amplitude
7.10%
Avg Price
3.148
Lot Size
1
Price Forecast

No Data

News

Comment